Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers

Summary

The study will consist of a screening period, 3 treatment periods and a post-treatment follow-up. In each of the 3 treatment periods, subjects will receive a single oral dose of GSK163090 in the fed or fasted state, followed by a 7-day wash-out period between each dose

Timeline

Start

2007-09-20

Primary completion

2007-11-05

Completion

2007-11-05

Drugs

Indications